Peptide-based agents for cancer treatment: current applications and future directions
Peptide-based strategies have received an enormous amount of attention because of their
specificity and applicability. Their specificity and tumor-targeting ability are applied to …
specificity and applicability. Their specificity and tumor-targeting ability are applied to …
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
FY Chiu, Y Yen - Biomarker Research, 2023 - Springer
Biomarker discovery and development are popular for detecting the subtle diseases.
However, biomarkers are needed to be validated and approved, and even fewer are ever …
However, biomarkers are needed to be validated and approved, and even fewer are ever …
Multimeric RGD-based strategies for selective drug delivery to tumor tissues
J Cossu, F Thoreau, D Boturyn - Pharmaceutics, 2023 - mdpi.com
RGD peptides have received a lot of attention over the two last decades, in particular to
improve tumor therapy through the targeting of the αVβ3 integrin receptor. This review …
improve tumor therapy through the targeting of the αVβ3 integrin receptor. This review …
Radionuclide imaging and therapy directed towards the tumor microenvironment: A multi-cancer approach for personalized medicine
CD van der Heide, SU Dalm - European Journal of Nuclear Medicine and …, 2022 - Springer
Targeted radionuclide theranostics is becoming more and more prominent in clinical
oncology. Currently, most nuclear medicine compounds researched for cancer theranostics …
oncology. Currently, most nuclear medicine compounds researched for cancer theranostics …
Systematic review: targeted molecular imaging of angiogenesis and its mediators in rheumatoid arthritis
F Khodadust, A Ezdoglian, MM Steinz… - International journal of …, 2022 - mdpi.com
Extensive angiogenesis is a characteristic feature in the synovial tissue of rheumatoid
arthritis (RA) from a very early stage of the disease onward and constitutes a crucial event …
arthritis (RA) from a very early stage of the disease onward and constitutes a crucial event …
RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions
RGD peptide can be found in cell adhesion and signaling proteins, such as fibronectin,
vitronectin, and fibrinogen. RGD peptides' principal function is to facilitate cell adhesion by …
vitronectin, and fibrinogen. RGD peptides' principal function is to facilitate cell adhesion by …
[HTML][HTML] Lasso peptide microcin J25 variant containing RGD motif as a PET probe for integrin av ß 3 in tumor imaging
K Mohri, KPH Nhat, M Zouda, S Warashina… - European Journal of …, 2023 - Elsevier
Abstract Microcin J25 (MccJ25), a lasso peptide, has a unique 3-D interlocked structure that
provides high stability under acidic conditions, at high temperatures, and in the presence of …
provides high stability under acidic conditions, at high temperatures, and in the presence of …
Peptide therapeutics in the management of metastatic cancers
D Bose, L Roy, S Chatterjee - RSC advances, 2022 - pubs.rsc.org
Cancer remains a leading health concern threatening lives of millions of patients worldwide.
Peptide-based drugs provide a valuable alternative to chemotherapeutics as they are highly …
Peptide-based drugs provide a valuable alternative to chemotherapeutics as they are highly …
Development of a Novel Peptide-Based PET Tracer [68Ga]Ga-DOTA-BP1 for BCMA Detection in Multiple Myeloma
L Song, S Jiang, Q Yang, W Huang, Y Qiu… - Journal of Medicinal …, 2024 - ACS Publications
B-cell maturation antigen (BCMA) has emerged as a promising tumor marker for the
diagnosis and treatment of multiple myeloma. The noninvasive and rapid detection of BCMA …
diagnosis and treatment of multiple myeloma. The noninvasive and rapid detection of BCMA …
Nanoparticle-based radioconjugates for targeted imaging and therapy of prostate cancer
A Lankoff, M Czerwińska, M Kruszewski - Molecules, 2023 - mdpi.com
Prostate cancer is the second most frequent malignancy in men worldwide and the fifth
leading cause of death by cancer. Although most patients initially benefit from therapy, many …
leading cause of death by cancer. Although most patients initially benefit from therapy, many …